Microbiota & Diseases, short as M&D, is planned to be launched soon in the beginning of the year 2023. Professor Yunsheng Yang from Chinese PLA General Hospital is invited as the Editor-in-Chief of the journal. The Editorial Board consists of outstanding professionals dedicated in the related field from all over the world.
Read more about Call for PaperAll vertebrates including humans are colonized by a huge number of microbes and microbiota has profound effects on human health and disease such as diet and obesity, aging, tumor, psychiatry, as well as immunity and inflammation. As the metagenomic and metabolomics techniques progress rapidly, microbiota is found to play a more and more important role not only inside the human body but also across the planet. However, current research is still in its infancy and there are many unknowns to explore. How to deep our understanding the complex interplay between the host and microbiota is challenging. Hence, joint efforts are needed and Microbiota & Diseases aims to be a leading platform in this field. We are sure that more and more novel therapeutic and preventive strategies for the disorders related to dysbiosis of the gut microbiota would appear within a 5-year timeframe.
Read more about Microbiota & Diseases: A new platform for the emerging science in microbiota
 |
Prof. Yunsheng Yang
Editor-in-Chief
Microbiota Division
Chinese PLA General Hospital, Beijing, China
|
.